In Wednesday’s Wall Street session, Medtronic Plc (NYSE:MDT) shares traded at $83.75, up 0.46% from the previous session.
MDT stock price is now -5.74% away from the 50-day moving average and -3.34% away from the 200-day moving average. The market capitalization of the company currently stands at $107.41B.
With the price target enhanced from $92 to $107, Citigroup Upgraded its rating from Neutral to Buy for Medtronic Plc (NYSE: MDT). On October 10, 2024, RBC Capital Mkts Upgraded its previous ‘Sector Perform’ rating to ‘Outperform’ on the stock increasing its target price from $98 to quote $105, while ‘Oppenheimer’ rates the stock as ‘Perform’
In other news, Wall Brett A., EVP & Pres Neuroscience sold 12,437 shares of the company’s stock on Jan 24 ’25. The stock was sold for $1,119,330 at an average price of $90.00. Upon completion of the transaction, the EVP & Pres Neuroscience now directly owns 40,979 shares in the company, valued at $3.43 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 24 ’25, Officer Wall Brett A. bought 12,437 shares of the business’s stock. A total of $1,119,330 was incurred on buying the stock at an average price of $90.00. A total of 0.12% of the company’s stock is owned by insiders.
During the past 12 months, Medtronic Plc has had a low of $75.96 and a high of $96.25. As of last week, the company has a debt-to-equity ratio of 0.54, a current ratio of 1.90, and a quick ratio of 1.43. According to the stock market information, the enterprise value for the company is $126326022144, which is based on a 25.46 price-to-earnings ratio, a 3.90 price-to-earnings-growth ratio, and a beta of 0.83. The fifty day moving average price for MDT is $88.9936 and a two-hundred day moving average price translates $86.61265 for the stock.
The latest earnings results from Medtronic Plc (NYSE: MDT) was released for 2025-01-24. The net profit margin was 12.83% and return on equity was 8.42% for MDT. The company reported revenue of $8.29 billion for the quarter, compared to $8.09 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 2.51 percent.
